BIT 3.33% 3.1¢ biotron limited

Ann: BIT225 Reverses HIV-Induced Immune Evasion, page-59

  1. J8
    14,554 Posts.
    lightbulb Created with Sketch. 823
    Commercial transaction may not have to be for HIV.

    Also, nothing stopping another trial (interruption) starting in the US, if Gilead or someone has a new drug to add to the current cocktail.
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.